News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Immune Pharmaceuticals Announces Strategic Partnership With the World-Renowned Weizmann Institute


5/23/2012 10:24:21 AM

HERZLIYA and REHOVOT, Israel, May 23, 2012 (GLOBE NEWSWIRE) -- IMMUNE Pharmaceuticals, an emerging leader in the development of monoclonal antibodies, and Yeda, the technology transfer company of the Weizmann Institute of Science, announced today a broad collaboration to develop antibody therapeutics targeting HER3, one of the most promising novel targets in oncology with early clinical validation.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES